tiprankstipranks
AnaptysBio Inc (ANAB)
NASDAQ:ANAB
US Market
Want to see ANAB full AI Analyst Report?

AnaptysBio (ANAB) Ratios

675 Followers

AnaptysBio Ratios

ANAB's free cash flow for Q4 2025 was $2.00. For the 2025 fiscal year, ANAB's free cash flow was decreased by $ and operating cash flow was $0.62. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
9.07 9.07 9.51 10.87 17.16
Quick Ratio
9.07 9.07 9.51 10.87 17.16
Cash Ratio
6.17 6.17 2.71 0.96 2.74
Solvency Ratio
-0.03 -0.03 -0.35 -0.45 -0.36
Operating Cash Flow Ratio
0.51 0.51 -2.98 -3.23 -2.82
Short-Term Operating Cash Flow Coverage
9.47 9.47 0.00 0.00 0.00
Net Current Asset Value
$ 23.07M$ 23.07M$ 18.91M$ 42.55M$ 98.92M
Leverage Ratios
Debt-to-Assets Ratio
0.80 0.04 0.76 0.04 0.03
Debt-to-Equity Ratio
7.81 0.38 5.21 0.20 0.07
Debt-to-Capital Ratio
0.89 0.27 0.84 0.17 0.07
Long-Term Debt-to-Capital Ratio
0.88 0.24 0.83 0.00 0.00
Financial Leverage Ratio
9.79 9.79 6.83 5.13 2.33
Debt Service Coverage Ratio
0.81 0.61 -1.85 -8.65 -4.99
Interest Coverage Ratio
0.60 0.60 -2.29 -9.09 -5.46
Debt to Market Cap
0.10 0.02 1.41 0.00 0.00
Interest Debt Per Share
13.33 3.38 14.78 1.33 1.44
Net Debt to EBITDA
0.79 -4.45 -2.66 0.12 0.49
Profitability Margins
Gross Profit Margin
98.97%98.97%-79.49%-671.01%-763.21%
EBIT Margin
27.42%20.42%-104.23%-915.50%-1045.90%
EBITDA Margin
28.45%21.45%-101.60%-911.70%-1023.20%
Operating Profit Margin
20.42%20.42%-125.93%-958.27%-1119.41%
Pretax Profit Margin
-5.57%-5.57%-159.10%-953.68%-1251.09%
Net Profit Margin
-5.64%-5.64%-159.10%-953.66%-1251.33%
Continuous Operations Profit Margin
-5.64%-5.64%-159.10%-953.66%-1251.33%
Net Income Per EBT
101.25%101.25%100.00%100.00%100.02%
EBT Per EBIT
-27.28%-27.28%126.34%99.52%111.76%
Return on Assets (ROA)
-3.63%-3.63%-30.02%-36.17%-21.09%
Return on Equity (ROE)
1813.85%-35.56%-204.93%-185.71%-49.11%
Return on Capital Employed (ROCE)
14.70%14.70%-26.22%-39.62%-19.71%
Return on Invested Capital (ROIC)
14.61%14.61%-26.11%-39.45%-19.65%
Return on Tangible Assets
-3.63%-3.63%-30.02%-36.17%-21.09%
Earnings Yield
-0.76%-1.47%-57.95%-28.37%-14.75%
Efficiency Ratios
Receivables Turnover
6.93 6.93 2.24 2.50 7.25
Payables Turnover
0.63 0.63 40.94 28.16 31.90
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
16.89 16.89 5.62 0.94 0.51
Asset Turnover
0.64 0.64 0.19 0.04 0.02
Working Capital Turnover Ratio
0.78 0.67 0.24 0.04 0.02
Cash Conversion Cycle
-530.46 -530.46 154.09 132.79 38.90
Days of Sales Outstanding
52.66 52.66 163.01 145.75 50.35
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
583.13 583.13 8.92 12.96 11.44
Operating Cycle
52.66 52.66 163.01 145.75 50.35
Cash Flow Ratios
Operating Cash Flow Per Share
0.71 0.71 -4.77 -4.49 -2.61
Free Cash Flow Per Share
0.71 0.71 -4.78 -4.52 -2.63
CapEx Per Share
<0.01 <0.01 0.01 0.03 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
226.40 226.40 -378.04 -149.69 -205.57
Capital Expenditure Coverage Ratio
226.40 226.40 -378.04 -149.69 -205.57
Operating Cash Flow Coverage Ratio
0.07 1.40 -0.37 -6.78 -3.78
Operating Cash Flow to Sales Ratio
0.08 0.08 -1.48 -7.04 -7.15
Free Cash Flow Yield
0.73%2.18%-54.15%-21.09%-8.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-140.21 -67.88 -1.73 -3.52 -6.78
Price-to-Sales (P/S) Ratio
12.27 3.83 2.75 33.61 84.85
Price-to-Book (P/B) Ratio
49.86 24.14 3.54 6.55 3.33
Price-to-Free Cash Flow (P/FCF) Ratio
146.81 45.80 -1.85 -4.74 -11.80
Price-to-Operating Cash Flow Ratio
94.19 45.60 -1.85 -4.77 -11.86
Price-to-Earnings Growth (PEG) Ratio
-0.70 0.75 0.11 -0.11 -0.06
Price-to-Fair Value
49.86 24.14 3.54 6.55 3.33
Enterprise Value Multiple
43.92 13.40 -5.36 -3.57 -7.80
Enterprise Value
2.74B 674.06M 497.00M 558.56M 820.98M
EV to EBITDA
41.06 13.40 -5.36 -3.57 -7.80
EV to Sales
11.68 2.87 5.44 32.56 79.81
EV to Free Cash Flow
139.76 34.37 -3.66 -4.59 -11.10
EV to Operating Cash Flow
139.14 34.22 -3.67 -4.62 -11.16
Tangible Book Value Per Share
1.34 1.34 2.50 3.27 9.31
Shareholders’ Equity Per Share
1.34 1.34 2.50 3.27 9.31
Tax and Other Ratios
Effective Tax Rate
-0.01 -0.01 >-0.01 <0.01 >-0.01
Revenue Per Share
8.44 8.44 3.22 0.64 0.37
Net Income Per Share
-0.48 -0.48 -5.12 -6.08 -4.57
Tax Burden
1.01 1.01 1.00 1.00 1.00
Interest Burden
-0.20 -0.27 1.53 1.04 1.20
Research & Development to Revenue
0.58 0.58 1.79 8.14 8.63
SG&A to Revenue
0.22 0.22 0.46 2.44 3.56
Stock-Based Compensation to Revenue
0.15 0.15 0.37 1.94 2.66
Income Quality
-1.49 0.40 0.93 0.74 0.57
Currency in USD